Ascendis Pharma
ASND
ASND
188 hedge funds and large institutions have $9.19B invested in Ascendis Pharma in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 50 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
+4
Holders Change %
+2.17%
% of All Funds
2.73%
Holding in Top 10
16
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
39
Increased
73
Reduced
50
Closed
33
Calls
$48.3M
Puts
$51.8M
Net Calls
-$3.49M
Net Calls Change
-$9.66M
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$139M |
| 2 |
Millennium Management
New York
|
+$51.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$50.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$43.2M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$35.4M |
